Europe EEG Machines Market Growth and Recent Trends by 2028

Europe EEG Machines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Integrated EEG and Portable EEG), Application (Disease Diagnosis, Sleep Monitoring, Anesthesia Monitoring Trauma and Surgery, and Others), and End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Research Laboratories, and Others)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028
  • Report Date : Mar 2022
  • Report Code : TIPRE00027729
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 134
Buy Now  
Europe EEG Machines Market Growth and Recent Trends by 2028
Report Date: Mar 2022   |   Report Code: TIPRE00027729
Buy Now
Page Updated: Mar 2022

The Europe EEG machines market is expected to reach US$ 568.51 million by 2028 from US$ 321.04 million in 2021; it is estimated to grow at a CAGR of 8.5% from 2021 to 2028.

The growth of the European EEG machines market is attributed to innovations for automated seizure detection in epilepsy and an increase in neurological disorders. However, the high cost of EEG machines is a key factor restraining the market growth.

The incidence of neurological disorders is significantly rising among older people. However, due to various factors such as stress, genetic mutations, lifestyle habits, and related chronic conditions, the incidences are seen among people of all age groups. It is estimated that there are over 600 neurologic disorders, among which Parkinson's, Huntington's, Alzheimer's, muscular dystrophy, stroke, meningitis, epilepsy, dementia, migraine, and brain tumors are commonly seen. Similarly, the growing geriatric population is expected to influence the incidence of neurological disorders. According to the World Health Organization (WHO) statistics, 2018, the total population over 60 years of age will grow at a rate of 22% by 2050 from 12% in 2015. According to the Federal Interagency Forum on Aging-Related Statistics published in 2016, 35.8% of people aged 85 years and above have moderate or severe memory impairment. Therefore, owing to the above-mentioned statistics, the demand for EEG machines is expected to increase, which, in turn, will propel market growth.

Epilepsy is among the commonly diagnosed neurological disorders among the population across the world. It affects ~2% of the total world's population. However, the diagnosis of epilepsy is merely done in developed countries where the healthcare technologies are well-developed. The diagnosis of epilepsy requires several days of EEG monitoring, which is interpreted by a trained neurologist, a neurophysiologist, or a skilled EEG reader. Epilepsy is undiagnosed in most cases in humans, or the treatment is delayed due to a late diagnosis. Therefore, it is essential to diagnose epilepsy at an early stage.

Technological developments provide a better scope to diagnose epilepsy seizures automatically. Various developments have been undertaken to devise technology for automated epilepsy seizure detection. For instance, in 2017, Google Inc. partnered with Cleveland Clinic's Epilepsy Center to develop an artificial intelligence (AI) system. The collaboration aims to integrate AI with the EEG machines that will help detect epileptic seizures automatically from long-term EEG recordings of patients who have been evaluated in Cleveland Clinic's epilepsy monitoring unit. Such innovations are expected to encourage more developments for EEG machines and create growth opportunities for the market players in the near future.

Countries in Europe were severely affected due to the COVID-19 pandemic. Italy, Spain, and France have reported the highest number of positive cases and have registered the maximum number of deaths.

The EEG machine market witnessed some shortfall at the beginning of the COVID-19 crisis, owing to disruption in supply chain and demand because of lockdowns announced by the majority of European countries. As per the news article by Euronews, in Italy, due to the COVID-19 emergency, access for thousands of cancer patients in need of chemotherapy, scans, transplants, and surgeries has become difficult. According to the research led by Codice Viola a charity that supports pancreatic cancer patients more than 1,000 surgery patient patients' appointments for chemotherapy or radiotherapy were suspended. Additionally, 64% of surgical procedures were postponed, and more than half have had follow-up appointments rescheduled. In the Netherlands, the healthcare system is under stress due to the rising number of COVID-19 patients.

Europe EEG Machines Market Revenue and Forecast to 2028 (US$ Mn)

Europe EEG Machines Market Revenue and Forecast to 2028 (US$ Mn)
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

EUROPE EEG MACHINES MARKET SEGMENTATION

By Product Type

  • Integrated EEG
  • Portable EEG

By Application

  • Disease Diagnosis
  • Trauma and Surgery
  • Sleep Monitoring
  • Anesthesia Monitoring
  • Others

By End User

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Research Laboratories
  • Others

By Country

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Company Profiles

  • Koninklijke Philips N.V.
  • Medtronic
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Fresenius SE & Co. KGaA
  • D & DJ BURTON HOLDINGS
  • Cephalon A/S
 

Europe EEG Machines Report Scope

Report Attribute Details
Market size in 2021 US$ 321.04 Million
Market Size by 2028 US$ 568.51 Million
CAGR (2021 - 2028) 8.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product Type
  • Integrated EEG and Portable EEG
By Application
  • Disease Diagnosis
  • Sleep Monitoring
  • Anesthesia Monitoring Trauma and Surgery
By End User
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Research Laboratories
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Koninklijke Philips N.V.
  • Medtronic
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Fresenius SE & Co. KGaA
  • D & DJ BURTON HOLDINGS
  • Cephalon A/S
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA